Please login to the form below

Not currently logged in
Email:
Password:

Cohn & Wolfe launch legal action

It has been reported that PR agency, Cohn & Wolfe is to begin legal proceedings against two former members of staff

Cohn & Wolfe is to launch legal proceedings against two former members of staff, dismissed from the agency last week.

According to reports, it is alleged that Fiona McMillan and Rebecca Galbraith, who resigned from the agency in December and were working out their notice periods, were dismissed last week for gross misconduct.

McMillan and Galbraith are reported to strongly deny any wrongdoing.

Cohn & Wolfe UK CEO Fiona Noble is said to have confirmed that 'solicitors have been retained by all parties involved, letters before action have been sent to them and legal proceedings are being prepared'.

Speaking to PR Week, Noble said: "We are taking legal action to obtain orders from the High Court requiring Fiona and Rebecca to act lawfully and in compliance with their Cohn & Wolfe employment contracts".

Cohn & Wolfe declined the opportunity to provide any further comments to PMLiVE.

21st January 2010

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Are you ready for the digital health revolution?
In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age....
#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...

Infographics